Zhong Ji Longevity Science Group Limited (HKG:0767)
0.4450
-0.0250 (-5.32%)
Jul 16, 2026, 2:07 PM HKT
HKG:0767 Revenue
In the year 2025, Zhong Ji Longevity Science Group had annual revenue of 126.10M HKD, down -25.22%. Zhong Ji Longevity Science Group had revenue of 78.79M in the half year ending December 31, 2025, with 151.34% growth.
Revenue
126.10M
Revenue Growth
-25.22%
P/S Ratio
2.37
Revenue / Employee
2.93M
Employees
43
Market Cap
299.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 126.10M | -42.52M | -25.22% |
| Dec 31, 2024 | 168.63M | 108.84M | 182.06% |
| Dec 31, 2023 | 59.78M | -40.54M | -40.41% |
| Dec 31, 2022 | 100.33M | 18.44M | 22.51% |
| Dec 31, 2021 | 81.89M | 19.38M | 31.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 6.61B |
| Adicon Holdings | 2.94B |
| Kindstar Globalgene Technology | 1.04B |
| Yunkang Group | 669.23M |
| Mega Genomics | 275.03M |
| Biosino Bio-Technology and Science Incorporation | 205.08M |
| King International Investment | 143.23M |
| Guanze Medical Information Industry (Holding) | 98.42M |